Boviseal is licensed for the prevention of new intramammary infections throughout the dry period. This  results in a reduction in the incidence of subclinical mastitis in the dry period and the subsequent lactation (for at least 60 days after calving). 

Infusion of Boviseal into each udder quarter produces a seal in the teat that provides an immediate and long lasting physical barrier to entry of bacteria and other mastitis causing organisms. 

Package Quantities: Buckets of 120 single dose intramammary syringes

Presentation: Grey to white coloured cream containing Bismuth subnitrate 2.6 g per syringe. Also contains liquid paraffin, aluminum di tri-stearate and colloidal anydrous silica. 

Withdrawal: zero days

LegalCategory:   LM              VPA Number:10387/096/001